Clinical trials and clinical practice

Norris, R M; Roy, Sitesh R.; Dixon, G; Stephens, Richard; Gibson, Della; Smith, George Davey; Egger, Matthias; Kiln, M R; Devlin, Hugh

doi:10.1016/0140-6736(93)92278-2

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1995

2004

Publication Types

Select...

Article6

Relationship

Self Cite0

Independent6

Authors

Journals

Cited by 8 publications

(1 citation statement)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The most frequent reason for thrombolytics not being given was atypical presentation, also identified Thrombolytics-a drug utilization review 337 (5). Contraindications preventing thrombolysis were present in three patients, a much lower frequency than found in other reports (3).…”

Section: Discussionmentioning

confidence: 89%

Thrombolytics-a drug utilization review in a district general hospital

Carruthers

Krska

1997

Journal of Clinical Pharmacy and Therapeutics

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 89%

Thrombolytics-a drug utilization review in a district general hospital

Carruthers

Krska

1997

Journal of Clinical Pharmacy and Therapeutics

View full text Add to dashboard Cite

show abstract

Antiarrhythmic Drug Prescription in Patients After Myocardial Infarction in the Last Decade

et al. 1995

View full text Add to dashboard Cite

show abstract

Cost-effectiveness of prescription recommendations for cholesterol-lowering drugs: A survey of a representative sample of american cardiologists

Gaspoz

Kennedy

Orav

et al. 1996

Journal of the American College of Cardiology

View full text Add to dashboard Cite

These findings suggest that the cardiologists' pharmacologic recommendations for lowering lipids are correlated with published cost-effectiveness analyses. However, substantial variation in their recommendations remains, with somewhat less aggressive treatment for secondary prevention and more aggressive treatment for primary prevention than would be recommended on the basis of cost-effectiveness analyses.

show abstract

Clinical trials and clinical practice

Cited by 8 publications

References 20 publications

Thrombolytics-a drug utilization review in a district general hospital

Thrombolytics-a drug utilization review in a district general hospital

Antiarrhythmic Drug Prescription in Patients After Myocardial Infarction in the Last Decade

Cost-effectiveness of prescription recommendations for cholesterol-lowering drugs: A survey of a representative sample of american cardiologists

Contact Info

Product

Resources

About